NYSE:CTV Innovid (CTV) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free CTV Stock Alerts $2.21 -0.16 (-6.75%) (As of 05:36 PM ET) Add Compare Share Share Today's Range$2.19▼$2.3550-Day Range$1.46▼$2.4952-Week Range$0.85▼$2.58Volume88,215 shsAverage Volume281,391 shsMarket Capitalization$313.42 millionP/E RatioN/ADividend YieldN/APrice Target$2.45 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Innovid alerts: Email Address Innovid MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside10.9% Upside$2.45 Price TargetShort InterestHealthy0.38% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.78Based on 7 Articles This WeekInsider TradingAcquiring Shares$66,020 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.97 out of 5 starsComputer And Technology Sector557th out of 585 stocksPrepackaged Software Industry190th out of 197 stocks 2.3 Analyst's Opinion Consensus RatingInnovid has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageInnovid has only been the subject of 3 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.38% of the float of Innovid has been sold short.Short Interest Ratio / Days to CoverInnovid has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Innovid has recently increased by 14.11%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldInnovid does not currently pay a dividend.Dividend GrowthInnovid does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CTV. Previous Next 3.2 News and Social Media Coverage News SentimentInnovid has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Innovid this week, compared to 2 articles on an average week.Search Interest6 people have searched for CTV on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Innovid to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Innovid insiders have bought more of their company's stock than they have sold. Specifically, they have bought $66,020.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 9.90% of the stock of Innovid is held by insiders.Percentage Held by InstitutionsOnly 25.46% of the stock of Innovid is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Innovid is -9.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Innovid is -9.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInnovid has a P/B Ratio of 1.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story About Innovid Stock (NYSE:CTV)Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies. The company serves consumer packaged goods, pharmaceutical and healthcare, retail, financial services, and automotive and technology industries; third party agencies; and publishers in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Innovid Corp. was incorporated in 2007 and is headquartered in New York, New York.Read More CTV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CTV Stock News HeadlinesApril 19, 2024 | finance.yahoo.comInnovid Wins "Best Measurement Tool" Category in the 2024 Digiday Video & TV AwardsApril 17, 2024 | americanbankingnews.comInnovid (NYSE:CTV) Given New $2.10 Price Target at Morgan StanleyApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 16, 2024 | finance.yahoo.comInnovid to Release First Quarter 2024 Financial Results on May 7thApril 16, 2024 | msn.comThe Trade Desk, Innovid rise as Morgan Stanley previews ad-tech earningsApril 11, 2024 | msn.comInnovid debuts Harmony initiative for connected TV measurementApril 11, 2024 | americanbankingnews.comInnovid (NYSE:CTV) Earns Market Outperform Rating from JMP SecuritiesApril 9, 2024 | finance.yahoo.comInnovid Launches Harmony Initiative to Keep TV Open for Everyone & Controlled by No OneApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 9, 2024 | americanbankingnews.comReviewing Innovid (NYSE:CTV) & Global-E Online (NASDAQ:GLBE)April 8, 2024 | finance.yahoo.comInnovid Corp. (CTV) Stock Historical Prices & Data - Yahoo FinanceMarch 20, 2024 | msn.comInnovid: CTV Accounted for More than Half of Video Ad Impressions in 2023March 20, 2024 | msn.comCTV Share Of Digital Video Impressions Rose To 53%, Innovid ReportsMarch 20, 2024 | businesswire.comInnovid's Annual CTV Insights Report Finds Interactive CTV Campaigns Drive Up to 10.3x Higher Engagement for AdvertisersMarch 6, 2024 | investing.comInnovid Corp. (CTV)March 5, 2024 | msn.comAdImpact Names Laia Pescetto VP of MarketingFebruary 29, 2024 | seekingalpha.comInnovid Corp. (CTV) Q4 2023 Earnings Call TranscriptFebruary 28, 2024 | finance.yahoo.comInnovid Corp. (NYSE:CTV) Q4 2023 Earnings Call TranscriptFebruary 28, 2024 | finance.yahoo.comInnovid to Participate in Upcoming Investor ConferencesFebruary 28, 2024 | businesswire.comInnovid to Participate in Upcoming Investor ConferencesFebruary 28, 2024 | markets.businessinsider.comInnovid’s Strong Financials and Market Positioning Garner Buy RatingFebruary 27, 2024 | markets.businessinsider.comInnovid Corp. Q4 loss drops in line with estimatesFebruary 27, 2024 | baystreet.caInnovid Clears Breakeven on Quarterly ResultsFebruary 27, 2024 | finance.yahoo.comInnovid Corp (CTV) Reports Solid Q4 and Full-Year 2023 Financial GrowthFebruary 27, 2024 | finance.yahoo.comInnovid Reports Q4 and Fiscal Year 2023 Financial ResultsFebruary 27, 2024 | prnewswire.comInnovid Reports Q4 and Fiscal Year 2023 Financial ResultsFebruary 26, 2024 | benzinga.comA Preview Of Innovid's EarningsSee More Headlines Receive CTV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovid and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today4/19/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Prepackaged software Sub-IndustryN/A Current SymbolNYSE:CTV CUSIPN/A CIK1835378 Webwww.ion-am.com Phone212-966-7555FaxN/AEmployees466Year FoundedN/APrice Target and Rating Average Stock Price Target$2.45 High Stock Price Target$3.00 Low Stock Price Target$2.10 Potential Upside/Downside+3.4%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-31,910,000.00 Net Margins-22.81% Pretax Margin-21.12% Return on Equity-8.92% Return on Assets-6.99% Debt Debt-to-Equity Ratio0.10 Current Ratio3.99 Quick Ratio3.99 Sales & Book Value Annual Sales$139.88 million Price / Sales2.40 Cash Flow$0.05 per share Price / Cash Flow46.70 Book Value$1.39 per share Price / Book1.71Miscellaneous Outstanding Shares141,820,000Free Float127,783,000Market Cap$336.11 million OptionableNot Optionable Beta3.31 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesProf. Zvika Netter (Age 51)Co-Founder, CEO & Chair of the Board Comp: $749.87kMs. Tanya Andreev-Kaspin (Age 46)Executive Officer Comp: $575.13kMr. Anthony Callini (Age 52)Chief Financial Officer Mr. Kenneth Markus (Age 49)Chief Operating Officer Mr. Yuval Pemper (Age 53)Chief Technology Officer John T. WilliamsHead of Investor RelationsMr. Stephen CookGeneral CounselMs. Dani Cushion (Age 46)Chief Marketing Officer Ms. Liel GolanSenior Vice President of Human ResourcesMs. Michal LivnySenior Vice President of People OperationsMore ExecutivesKey CompetitorsPorch GroupNASDAQ:PRCHMiX TelematicsNYSE:MIXTAmerican SoftwareNASDAQ:AMSWABackblazeNASDAQ:BLZEMaterialiseNASDAQ:MTLSView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 121,394 shares on 3/11/2024Ownership: 3.015%Goldman Sachs Group Inc.Sold 624,096 shares on 3/1/2024Ownership: 0.060%Anthony CalliniBought 11,000 shares on 2/29/2024Total: $20,020.00 ($1.82/share)Zvika NetterBought 25,000 shares on 2/28/2024Total: $46,000.00 ($1.84/share)GSA Capital Partners LLPSold 81,057 shares on 2/16/2024Ownership: 0.244%View All Insider TransactionsView All Institutional Transactions CTV Stock Analysis - Frequently Asked Questions Should I buy or sell Innovid stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Innovid in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CTV shares. View CTV analyst ratings or view top-rated stocks. What is Innovid's stock price target for 2024? 3 Wall Street analysts have issued 12-month target prices for Innovid's shares. Their CTV share price targets range from $2.10 to $3.00. On average, they predict the company's stock price to reach $2.45 in the next year. This suggests a possible upside of 10.9% from the stock's current price. View analysts price targets for CTV or view top-rated stocks among Wall Street analysts. How have CTV shares performed in 2024? Innovid's stock was trading at $1.50 at the start of the year. Since then, CTV stock has increased by 47.3% and is now trading at $2.21. View the best growth stocks for 2024 here. Are investors shorting Innovid? Innovid saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 338,800 shares, an increase of 14.1% from the March 15th total of 296,900 shares. Based on an average daily volume of 291,700 shares, the short-interest ratio is currently 1.2 days. Currently, 0.4% of the company's shares are sold short. View Innovid's Short Interest. When is Innovid's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our CTV earnings forecast. How can I listen to Innovid's earnings call? Innovid will be holding an earnings conference call on Tuesday, May 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link. How were Innovid's earnings last quarter? Innovid Corp. (NYSE:CTV) announced its quarterly earnings results on Tuesday, February, 27th. The company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01). The firm earned $38.62 million during the quarter, compared to analysts' expectations of $36.90 million. Innovid had a negative net margin of 22.81% and a negative trailing twelve-month return on equity of 8.92%. During the same quarter in the prior year, the business posted ($0.03) EPS. What guidance has Innovid issued on next quarter's earnings? Innovid updated its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $34.0 million-$36.0 million, compared to the consensus revenue estimate of $33.1 million. How do I buy shares of Innovid? Shares of CTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CTV) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovid Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.